Gleneagles Hospital Chennai launched the two-day Gleneagles Liver and Transplant Summit (GLTS) 2025 at Chennai.
Held under the theme “Advancing Science, Enhancing Lives,” the summit serves as a dynamic platform for collaboration among clinicians, surgeons, researchers, and transplant specialists from India and abroad. The summit was inaugurated by Dr Nageswar Rao K, Cluster CEO – Chennai & Hyderabad, alongside Dr Joy Varghese, Director of Hepatology & Transplant Hepatology at Gleneagles Hospital Chennai.
GLTS 2025 explores the latest innovations in liver transplantation, with dedicated sessions on paediatric transplants, ABO-incompatible procedures, and complex dual lobe and swap transplants. The scientific agenda extends into a multidisciplinary space, encompassing developments in hepatology, anaesthesiology, radiology, and pathology. With participation from over 40 national and international faculty members and an expected audience of more than 500 medical professionals, the summit promises to foster deep knowledge exchange and meaningful partnerships.
“Gleneagles Hospital Chennai has successfully performed over 2,500 liver transplants and established itself as a centre of excellence in multi-organ transplantation,” said Dr Nageswar Rao. “GLTS 2025 strengthens our commitment to advancing clinical knowledge, improving outcomes, and raising standards of care through collaboration.”
Dr Joy Varghese added, “This summit highlights India’s growing leadership in liver transplantation. More than just a scientific gathering, it exemplifies the spirit of teamwork, multidisciplinary synergy, and continuous learning that directly benefits patients.”
Key themes of GLTS 2025 include a strong focus on paediatric liver transplantation, ABO-incompatible cases, and technically complex procedures such as dual lobe transplants. The programme also features discussions on transplant-related anaesthesia, radiology, hepatology, and pathology, offering a comprehensive overview of current practice and future directions. Additionally, the summit showcases some of India’s leading innovations in liver disease management, while providing valuable networking opportunities for over 500 delegates engaging with more than 40 national and international experts.
GLTS 2025 is more than an academic event — it is a powerful reminder of what can be achieved through collaboration, innovation, and shared purpose in the field of liver care.
Related Stories
Fortis Leads the Way in Building a Nation of First Responders
When a cardiac emergency strikes, survival often depends on what happens in the first few minutes. Before an ambulance arrives. Before hospital doors open. In those moments, a trained bystander can mean the difference between life and loss.
.png?sfvrsn=36e1af94_1)
Fortis Hospital Bannerghatta Road Successfully Treats Rare Nasal Tumour in Teen
After nearly two years of misdiagnosis, a 14-year-old boy suffering from a rare nasal tumour found a new lease of life at Fortis Hospital Bannerghatta Road.
Mount Elizabeth’s Revitalisation Sets a New Benchmark for Patient-Centred Care in the Region
IHH Healthcare Singapore is strengthening its legacy of care through the revitalisation of Mount Elizabeth Hospital (MEH), a flagship institution that has supported patients from Singapore, Indonesia and across the region for more than 45 years.
Fortis Charts the Future of Haematology
On 22 and 23 November, Fortis Memorial Research Institute, Gurugram (Fortis Gurugram) hosted HemeNext 1.0, a pioneering national conference exploring how genomics, artificial intelligence, robotics and advanced cell therapies are reshaping haematology and infectious disease care across India.
Proudly the First: IHH Healthcare Singapore Achieves Full National Electronic Health Record Participation
IHH is proud to be the first private healthcare group in Singapore with all four hospitals fully contributing to the National Electronic Health Record (NEHR), reflecting our steadfast commitment to advancing continuity of care and building a more connected, patient-centred healthcare ecosystem.
